Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,925 USD | +0,36% | +0,44% | -5,74% |
Omzet 2024 * | 23,95 mln. 22,48 mln. | Omzet 2025 * | 72,18 mln. 67,76 mln. | Marktkapitalisatie | 293 mln. 275 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -76 mln. -71,34 mln. | Nettowinst (verlies) 2025 * | -39 mln. -36,61 mln. | EV/omzet 2024 * | 12,2 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 4,06 x |
K/w-verhouding 2024 * |
-4,45
x | K/w-verhouding 2025 * |
-8,73
x | Werknemers | 100 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 43,45% |
Recentste transcriptie over Verrica Pharmaceuticals Inc.
1 dag | +0,36% | ||
1 week | +0,44% | ||
Lopende maand | +16,55% | ||
1 maand | +45,57% | ||
3 maanden | +16,75% | ||
6 maanden | +94,92% | ||
Lopend jaar | -5,74% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ted White
CEO | Chief Executive Officer | 59 | 01-12-17 |
Terence Kohler
DFI | Director of Finance/CFO | 46 | 16-07-21 |
Compliance Officer | 60 | 01-09-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mark Prygocki
BRD | Director/Board Member | 58 | 01-05-18 |
Paul Manning
CHM | Chairman | 68 | 01-12-15 |
Craig Ballaron
BRD | Director/Board Member | 63 | 13-06-19 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.00% | 34 M€ | +1,27% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 6,92 | +0,29% | 35 955 |
18-04-24 | 6,9 | -2,27% | 202 527 |
17-04-24 | 7,06 | +0,86% | 105 357 |
16-04-24 | 7 | +1,16% | 89 905 |
15-04-24 | 6,92 | +0,73% | 163 836 |
uitgestelde koers Nasdaq, 19 april 2024 om 20:17 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,74% | 293 mln. | |
+24,86% | 672 mld. | |
+24,08% | 550 mld. | |
-6,14% | 351 mld. | |
+15,32% | 317 mld. | |
+6,77% | 292 mld. | |
+3,26% | 211 mld. | |
+0,78% | 203 mld. | |
-10,26% | 144 mld. | |
-7,09% | 141 mld. |